Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window
timothy sykes logo

Stock News

Hims & Hers: Navigating Financial Challenges

Tim SykesAvatar
Written by Timothy Sykes Reviewed by Bryce Tuohey Fact-checked by Matt Monaco
Updated 10/17/2025, 9:19 am ET | 6 min
Hims & Hers: Navigating Financial Challenges Thumbnail

In this article Last trade Nov, 28 5:00 PM

  • HIMS+3.72%
    HIMS - NYSEHims & Hers Health Inc. Class A
    $39.83+1.43 (+3.72%)
    Volume:  12.34M
    Float:  205.13M
    $38.52Day Low/High$39.88

Hims & Hers Health Inc. stocks have been trading down by -2.4 percent amid market reactions to strategic shifts in healthcare delivery.

  • The Chief Financial Officer, Oluyemi Okupe, made waves when he sold a significant number of shares recently, netting over $1.3M. Such financial maneuvers send ripples through the shareholder community.

  • Legal clouds have gathered as Berger Montague investigates potential fiduciary breaches linked to a frozen collaboration with Novo Nordisk, following claims of dubious marketing tactics.

Candlestick Chart

Live Update At 09:18:37 EST: On Friday, October 17, 2025 Hims & Hers Health Inc. stock [NYSE: HIMS] is trending down by -2.4%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Financial Insights: Earnings and Outlook

When looking into penny stocks, it’s crucial to understand the various elements at play. Many traders believe the key lies in understanding market trends and keeping up to date with news that might affect stock prices. However, the reality of trading involves many unexpected turns. As millionaire penny stock trader and teacher Tim Sykes says, “Embrace the journey, the ups and downs; each mistake is a lesson to improve your strategy.” It’s essential for traders to learn from every experience, adjusting their methods to better adapt to ongoing market changes. By doing so, they can significantly enhance their chances of success in unpredictable trading environments.

Hims & Hers Health Inc. offers a unique lens into the fluid world of health services, casting a long shadow from its headquarters to Wall Street. A key narrative unfolds in the numbers, where revenue shines at $1.47B, revealing the company’s colossal strides. Yet, cracks start to show when the per-share revenue is juxtaposed – cautioning investors about a thin line between growth and unsustainable exuberance.

The profitability margins raise eyebrows. The company’s gross margin stands at 76.2%, demonstrating insulation against cost hikes and effective management—yet the pretax profit margin dips into negative territory. This complex concoction uncovers the industry’s pressures and substandard earnings relative to its revenues.

Observing through another prism, valuation metrics place HIMS in an arena of lofty ambitions. With a PE ratio nearing 80, investors wager on future promise rather than current stability. The intrigue deepens with a price-to-book ratio above 25, spotlighting the premium tagged onto each dollar’s worth of equity. These metrics highlight an electrifying tale of risk and reward.

In terms of assets, dynamism is encapsulated in the firm’s high asset turnover, clocking in at 1.7. This reflects the nimbleness of the firm to leverage assets into revenue—a hallmark of dynamic business prowess.

Amid stock juggernauts, HIMS paws at the debt wall, with total liabilities veiled in an intricate tapestry of $1.31B, balancing out its equity narrative. A concerning wave arises from the liabilities eclipsing half of the trio – assets, equity, and eminence in financial power play.

Financial reports echo an unpredictable journey in cash flow, revealing a substantial ending cash position of $903.5M—a silver lining! Yet, amidst the glint, springs a whirlpool of declines, as observed in operating cash flow sagging into negatives. The cash flow diversions and restructuring bear hues of strategic recalibrations focused on long-term navigation rather than immediate gains.

Transformative Narratives in Market

The legal developments surrounding Hims & Hers seem to create a loud echo in the financial corridors. The accidented withdrawal from Novo Nordisk grips the market. Not for the faint of heart, this tale of disputes sprouting from alleged deceptive marketing practices puts HIMS at a crossroads.

The saga of insider selling weaves threads of shareholder unease and strategic chess moves. The sheer volumes swung by leading insiders such as Oluyemi Okupe prompt murmurs of doubt back at the boardroom. Yet, it might also signify strategic reorganization—a cleaving off old to embrace the new, as one might say.

More Breaking News

What’s Next for Investors and Market?

As Hims & Hers traverses this financial landscape, blending narratives of highs and crosscurrents surrounding operational challenges, traders might ponder the future prospects lined with both golden potential and cautionary tales. Legal clouds, shifting financial terrains, and high-stake boardroom chess dictate the course ahead. As millionaire penny stock trader and teacher Tim Sykes says, “Preparation plus patience leads to big profits.” Such wisdom might serve as a guiding principle for those analyzing the tumultuous journey of HIMS.

Yet, despite the rocky patches, HIMS embodies the disruptive spirit of healthcare services. As traders navigate this spirited ride, the onus remains to keep a finger on the pulse of market vibrations and the company’s strategic pivot—to balance on the edge of risk and fruition. The questions persist: Is it a time of opportunity as the company endeavors to steer toward brighter shores, or should wary eyes await further recalibration?

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Tim Sykes

Head Writer at TimothySykes.com, Lead Mentor at the Trading Challenge
In his 20-plus years of trading, Tim has made $7.9 million. In his 15-plus years of teaching, Tim’s Trading Challenge has produced over 30 millionaire students. His philosophy emphasizes small gains and cutting losses quickly.
Read More

In this article (YTD Performance)

  • HIMS+64.43%
    HIMS - NYSEHims & Hers Health Inc. Class A
    $39.83+1.43 (+3.72%)
    Volume:  12.34M
    Float:  205.13M
    $38.52Day Low/High$39.88

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”

ts swipe photo
Learn The Formula That Has Created Over 50 Millionaires
TRADE LIKE TIM
notification icon
Subscribe to receive notifications